Medical/scientific intelligence - Six-target competitive R&D assessment in diabetes

Background and objectives

Our client engaged us to support their efforts in a 6-target R&D assessment of the current and planned R&D diabetes treatment discovery landscape. KITs included:

• Current scientific development including status, approach and theories
• Clinical trial intelligence (phase 1 - phase 3)
• Product development road map
• Product lifecycle management strategy

Approach

A team of six research analysts was assembled to support the primary research efforts of the project.

Primary research efforts focused on KOLs, clinical trial partners and research scientists, as well as attendance at major medical conferences and symposiums. Project duration was three months.

Results delivered

• We were able to provide detailed intelligence concerning the development strategy for all six targets.
• We were able to provide detailed clinical trial data on five clinical trials.
• We were able to gain detailed insight from KOLs concerning the various development strategies of the targeted competitors.
• We provided a SWOT analysis of the client's development strategy in comparison to the targeted competitors.
• We provided a detailed development timeline for each competitor which provided the client with an effective and efficient benchmarking tool.